Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery

Recruiting Observational Study
Arthropathy of Hip
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
630 (estimated)
Sponsor
Gruppo Bioimpianti S.r.l. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Post-market clinical follow up investigation on the use of saphir stem and FIN Cup or Dualis system in the treatment of pathologies requiring hip arthroplasty. The main object of the clinical investigation is the evaluation of long term survival rate of Saphir stem.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients\>18 years * Candidate for primary total hip replacement with femoral stem and acetabular cup * if ostheoarthritis patients aged 18 to 85 years * if femoral neck fracture patients aged 18 to 90 years * patients with social security scheme * patients understands the con…
Contacts

Alessio Vitale, Biotech

+390251650371

regulatory@bioimpianti.it

CONTACT

Fabio Stringhi, biomedic eng

patients under guardianship or

fabio.stringhi@bioimpianti.it

CONTACT